论文部分内容阅读
选择具有高中和活性和血凝抑制活性，且对肾综合征出血热病毒（ＨＦＲＳＶ）感染乳鼠具有良好保护作用的抗－ＨＦＲＳＶＭｃＡｂ腹水，经辛酸－硫酸铵沉淀法纯化成ＩｇＧ。在纯度鉴定、免疫学活性测定及各种安全性试验合格的基础上，首次试用于３例ＨＦＲＳ患者的治疗。结果表明，使用安全，疗效良好。随访观察１１个月，无异常反应。
Anti-HFRSVMcAb ascites with high school activity and hemagglutination inhibition activity and good protection against neonatal Hemorrhagic Fever with Renal Syndrome (HFRSV) infection was selected and purified by caprylate-ammonium sulfate precipitation. On the basis of purity identification, immunological activity determination and all kinds of safety tests, it was first tested in 3 HFRS patients. The results show that the use of safe, good effect. Follow-up observation of 11 months, no abnormal reaction.